Cigarette smoking and incident chronic kidney disease: A systematic review

American Journal of Nephrology

Volumn 27, Issue 4, 2007, Pages 342-351

  Jones Burton, Charlotte ^a,d   Seliger, Stephen L ^a   Scherer, Roberta W ^b   Mishra, Shiraz I ^a   Vessal, Ghazal ^c   Brown, Jeanine ^a   Weir, Matthew R ^a   Fink, Jeffrey C ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

Author keywords

Cigarette smoking; Incident chronic kidney disease; Systematic review, cigarette smoking kidney disease development association

Indexed keywords

CHRONIC KIDNEY DISEASE; CIGARETTE SMOKING; CONFIDENCE INTERVAL; DATA BASE; EMBASE; GENDER; HUMAN; MEDLINE; PEER REVIEW; PRIORITY JOURNAL; REVIEW; RISK; RISK FACTOR;

HUMANS; KIDNEY FAILURE, CHRONIC; RESEARCH DESIGN; SMOKING;

EID: 34447577983     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103382     Document Type: Review

References (44)

1. Chapman AB, Johnson AM, Gabow PA, et al: Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1994;5:1349-1354.
2. Chuahirun T, Khanna A, Kimball K, et al: Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes. Am J Kidney Dis 2003;41:13-21.
3. Gambaro G, Verlato F, Budakovic A, et al: Renal impairment in chronic cigarette smokers. J Am Soc Nephrol 1998;9:562-567.
4. Odoni G, Ogata H, Viedt C, et al: Cigarette smoke condensate aggravates renal injury in the renal ablation model. Kidney Int 2002;61:2090-2098.
5. Orth SR: Smoking and the kidney. J Am Soc Nephrol 2002;13:1663-1672.
6. Ward MM, Studenski S: Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Arch Intern Med 1992;152:2082-2088.
7. Lhotta K, Rumpelt HJ, König P, et al: Cigarette smoking and vascular pathology in renal biopsies. Kidney Int 2002; 61: 648-654.
8. Jee SH, Boulware LE, Guallar E, et al: Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study. Arch Intern Med 2005;165:2299-2304.
9. Orth SR, Schroeder T, Ritz E, et al: Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus. Nephrol Dial Transplant 2005;20:2414-2419.
10. Gambaro G, Bax G, Fusaro M, et al: Cigarette smoking is a risk factor for nephropathy and its progression in type 2 diabetes mellitus. Diabetes Nutr Metab 2001;14:337-342.
11. Klein R, Klein BE, Moss SE: Incidence of gross proteinuria in older-onset diabetes. A population-based perspective. Diabetes 1993;42:381-389.
12. Yaqoob M, Bell GM, Percy DF, et al: Primary glomerulonephritis and hydrocarbon exposure: a case-control study and literature review. Q J Med 1992;83:409-418.
13. Norden G, Nyberg G: Smoking and diabetic nephropathy. Acta Med Scand 1984;215:257-261.
14. Goetz FC, Jacobs DR Jr, Chavers B, et al: Risk factors for kidney damage in the adult population of Wadena, Minnesota. A prospective study. Am J Epidemiol 1997;145:91-102.
15. Almdal T, Norgaard K, Feldt-Rasmussen B, et al: The predictive value of microalbuminuria in IDDM. A five-year follow-up study. Diabetes Care 1994;17:120-125.
16. Reichard P, Rosenqvist U: Nephropathy is delayed by intensified insulin treatment in patients with insulin-dependent diabetes mellitus and retinopathy. J Intern Med 1989;226:81-87.
17. Royal College of Physicians of Edinburgh Diabetes Register Group: Near-normal urinary albumin concentrations predict progression to diabetic nephropathy in type 1 diabetes mellitus. Diabet Med 2000;17:782-791.
18. Regalado M, Yang S, Wesson DE: Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension. Am J Kidney Dis 2000;35:687-694.
19. Wakai K, Kawamura T, Ohno Y, et al: Lifestyles and renal damage - association of smoking, drinking and physical activity with subsequent proteinuria (in Japanese). Nippon Koshu Eisei Zasshi 1995;42:243-248.
20. Harris RP, Helfand M, Woolf SH, et al: Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 2001;20:21-35.
21. Colhoun HM, Lee ET, Bennett PH, et al: Risk factors for renal failure: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001;44(suppl 2):S46-S53.
22. Haroun MK, Jaar BG, Hoffman SC, et al: Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 2003;14:2934-2941.
23. Krop JS, Coresh J, Chambless LE, et al: A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities study. Arch Intern Med 1999;159:1777-1783.
24. Stengel B, Couchoud C, Cenee S, et al: Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies. Kidney Int 2000;57:2519-2526.
25. Klein R, Klein BE, Moss SE, et al: Ten-year incidence of gross proteinuria in people with diabetes. Diabetes 1995;44:916-923.
26. Stengel B, Tarver-Carr ME, Powe NR, et al: Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology 2003;14:479-487.
27. Ejerblad E, Fored CM, Lindblad P, et al: Association between smoking and chronic renal failure in a nationwide population-based case-control study. J Am Soc Nephrol 2004;15:2178-2185.
28. Fox CS, Larson MG, Leip EP, et al: Predictors of new-onset kidney disease in a community-based population. JAMA 2004;291:844-850.
29. Lee ET, Lee VS, Lu M, et al: Incidence of renal failure in NIDDM. The Oklahoma Indian Diabetes Study. Diabetes 1994;43:572-579.
30. Yokoyama H, Okudaira M, Otani T, et al: High incidence of diabetic nephropathy in early-onset Japanese NIDDM patients. Risk analysis. Diabetes Care 1998;21:1080-1085.
31. Kopczynski J, Janeczko D, Lewandowski Z, et al: Risk factors of the incidence of late vascular complications of diabetes (in Polish). Pol Arch Med Wewn 1998;100:236-244.
32. Kulenovic I: Risk factors for the development of persistent proteinuria in patients with type 2 diabetes mellitus (in Croatian). Med Arh 2002;56:71-72.
33. Bleyer AJ, Shemanski LR, Burke GL, et al: Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population. Kidney Int 2000;57:2072-2079.
34. Tozawa M, Iseki K, Iseki C, et al: Influence of smoking and obesity on the development of proteinuria. Kidney Int 2002;62:956-962.
35. Ferreira SR, Pinto FM: Factors associated with the development of renal complications of diabetes mellitus in São Paulo city. Braz J Med Biol Res 1997;30:735-744.
36. Ritz E, Benck U, Franek E, et al: Effects of smoking on renal hemodynamics in healthy volunteers and in patients with glomerular disease. J Am Soc Nephrol 1998;9:1798-1804.
37. Pawlik WW, Jacobson ED, Banks RO: Actions of nicotine on renal function in dogs. Proc Soc Exp Biol Med 1985;178:585-590.
38. Rowe JW, Kilgore A, Robertson GL: Evidence in man that cigarette smoking induces vasopressin release via an airway-specific mechanism. J Clin Endocrinol Metab 1980;51:170-172.
39. Cryer PE, Haymond MW, Santiago JV, et al: Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976;295:573-577.
40. Benck U, Clorius JH, Zuna I, et al: Renal hemodynamic changes during smoking: effects of adrenoreceptor blockade. Eur J Clin Invest 1999;29:1010-1018.
41. Haak T, Jungmann E, Raab C, et al: Elevated endothelin-1 levels after cigarette smoking. Metabolism 1994;43:267-269.
42. Obata T, Tomaru K, Nagakura T, et al: Smoking and oxidant stress: assay of isoprostane in human urine by gas chromatographymass spectrometry. J Chromatogr B Biomed Sci Appl 2000;746:11-15.
43. Hill G, Connelly J, Hebert R, et al: Neyman's bias re-visited. J Clin Epidemiol 2003;56:293-296.
44. Stroup DF, Berlin JA, Morton SC, et al: Metaanalysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-2012.